General Information
Version
1.0
Revision date
2019-10-29
Product name
Spiropent tablets (finished product)
Product Synonyms
Spiropent® 0.02 mg tablets, Risopent® tablets Active ingredient: Clenbuterol hydrochloride
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user on use
Icons in SDS
Company Information
company name
Boehringer Ingelheim Vetmedica
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. The pharmacological effect of the medicament has to be considered (see package leaflet). This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)
